Gefitinib Eg

Gefitinib Eg is an oral medication used to treat certain types of cancer. It works by targeting specific proteins in cancer cells to help slow their growth. This medication is manufactured by Eurogenerics N.V./S.A.

Gefitinib Eg is primarily used in the treatment of non-small cell lung cancer (NSCLC) that has spread or cannot be removed by surgery. It is designed to target and inhibit the growth of cancer cells that have specific genetic mutations. Patients often wonder, 'What is Gefitinib Eg used for?' It is typically prescribed for advanced stages of NSCLC where other treatments may not be effective.

Common effects of Gefitinib Eg may include skin rash, diarrhea, and appetite loss. Some users may experience dry skin or changes in their nails. These effects can vary in intensity and duration, depending on individual responses to the medication.

Gefitinib Eg should be handled with care, especially by those with pre-existing medical conditions such as liver or kidney problems. It is important to follow the advice of a healthcare professional regarding its use. Always store the medication as directed to maintain its effectiveness.

Gefitinib Eg may interact with certain medications, including those that affect liver enzymes. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and other substances may also affect how Gefitinib Eg works in the body.